Alshehri, E. (2026) The Diagnostic Conundrum of Recurrent High-Grade Vaginal Intraepithelial Neoplasia (VAIN) Following ...

FREMONT, Calif.--(BUSINESS WIRE)-- Personalis, Inc (PSNL). (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, announced the presentation of new results from the CALLA phase 3 study ...

Cervical cancer remains one of the most challenging diseases in oncology, with high recurrence rates and significant treatment side effects. For decades, the standard approach has relied on a ...

Early detection and modern treatments make cervical cancer one of the most preventable and treatable cancers. Newport Women’s ...

In a population-based cohort of 15- to 39-year-olds diagnosed with cancer, the risk for metastatic recurrence varied widely by cancer type and stage, and survival after recurrence was worse than after ...

(RTTNews) - Zai Lab Limited (ZLAB) announced that China's National Medical Products Administration or NMPA has accepted the Biologics License Application or BLA for TIVDAK (tisotumab vedotin-tftv) for ...

A new study of adolescents and young adults (AYAs) with seven common cancers reveals that nearly one in ten patients diagnosed with non-metastatic disease later develop metastatic recurrence — a ...

Human Papillomavirus HPV infection causes almost all cases of cervical cancer Our expert explains what HPV is its causes ...

A GP has issued an urgent warning about a "noticeable" cancer symptom that women could be missing. The doctor emphasises this ...

“We are excited to see the results presented for NeXT Personal in this large phase 3 study in cervical cancer,” said Richard Chen, MD, Chief Medical Officer and Executive Vice President, R&D at ...